Nasdaq biol.

Predictive Oncology (NASDAQ: POAI) Biolase (NASDAQ: BIOL) CohBar (NASDAQ: CWBR) Vista Gold (NYSEAMERICAN: VGZ) Calyxt (NASDAQ: CLXT) Clearside Biomedical (NASDAQ: CLSD) Penny Stocks Under $3 .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will participate in the H.C. Wainwright BIOCONNECT Virtual...May-24-23 09:14AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants. (PR Newswire) -39.91%. May-11-23 04:36PM. Biolase: Q1 Earnings Snapshot.FOOTHILL RANCH, Calif., March 25, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...

Exhibit 99.1 . BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023 . Lake Forest, Calif., July 26, 2023 – BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced that it held a special …FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...

BIOLASE, Inc. (BIOL). NASDAQ: BIOL · IEX Real-Time Price · USD.

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Spring Into Action...The answer lies in Nasdaq rules that give companies generous grace periods for companies trying to get their share price back above $1. Under the rules, a company …BIOL stock is up 44% year-to-date, but it’s literally a penny stock trading at about 70 cents a share, with a $101 million market cap. The stock has a B-rating in my Portfolio Grader . Best ...LAKE FOREST, Calif., June 30, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that, on June 30, 2022, it entered into an amendment to its senior ...

The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ...

May 2, 2022 · Find the latest news headlines from Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.

BIOLASE, Inc. (NASDAQ:BIOL) fell 43.3% to $1.85 in pre-market trading after the company announced pricing of $4.5 million underwritten public offering of Series J convertible redeemable preferred ...The stock was up 8.89% to $3.43 in after-hours trading. Agios Reports Positive Phase 3 Data For Mitapivat In Treating Genetic Blood Disorder. Agios Pharmaceuticals Inc (NASDAQ:AGIO) said that the ...The Wall Street analyst predicted that Biolase's share price could reach $40.00 by May 31, 2024. The average Biolase stock price prediction forecasts a ...Oct 20, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No ... IRVINE, Calif., June 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with ...

Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical reporting …/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will participate in the H.C. Wainwright BIOCONNECT Virtual...Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W... Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...Nov 27, 2023 · Research BIOLASE's (Nasdaq:BIOL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...FOOTHILL RANCH, Calif., Jan. 6, 2022 /PRNewswire/-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ...

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific ...BIOLASE, Inc. (NASDAQ:BIOL) rose 9% to $0.5707 in pre-market trading after gaining 9% on Friday. The company, last month, was granted US patent for 'Dental laser interface system and method.'

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific ...FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...An analysis of the stock market reaction to the announcements of the UK Soft Drinks Industry Levy. Econ Hum Biol. 2020 Aug:38:100834. doi: 10.1016/j.ehb ...CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today …Biolase price target lowered to $3.00 from $5.00 at Maxim November 15, 2023TipRanks. Positive Clinical Trial Results and Successful Cost Optimization Initiatives Bolster Buy Rating for Biolase ...FOOTHILL RANCH, Calif., Jan. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary ...

3 Oct 2023 ... Math. Biol. Neurosci. ISSN 2052-2541. Editorial Office: [email protected]. Copyright ©2023 CMBN.

May 11, 2023 · LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 ...

Dec 1, 2023 · Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. 03 Mar, 2021, 09:00 ET. IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today that the company has formed a community of ...Dec 5, 2023 · BIOL) stock’s latest price update. Biolase Inc (NASDAQ: BIOL) has experienced a rise in its stock price by 31.30 compared to its previous closing price of 1.15. However, the company has seen a gain of 30.17% in its stock price over the last five trading days. Benzinga reported 2023-08-04 that The most oversold stocks in the health care sector ... At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...LAKE FOREST, Calif., Sept. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously ...2 analysts have issued 1-year price objectives for BIOLASE's shares. Their BIOL share price targets range from $4.00 to $150.00. On average, they anticipate the company's stock price to reach $77.00 in the next year. …CAMBRIDGE, Mass., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today …Jan 31, 2023 · Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...

LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 ...FOOTHILL RANCH, Calif., Feb. 23, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the Board of Directors has appointed John R. Beaver, the ...How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. Instagram:https://instagram. us cellular stocksbest broker to buy cryptocurrencynext ex dividend datebest dental insurance plans in maryland BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.FDA has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or … jtblu stockkmi company Jan 25, 2023 · FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ... U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.61% to 34,784.94 while the NASDAQ rose 0.71% to 13,911.78 ... v.f. stock H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused …01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...BIOLASE (NASDAQ:BIOL – Get Free Report) last posted its earnings results on Thursday, August 10th. The medical technology company reported ($8.93) earnings per share (EPS) for the quarter.